Thu Nov 21 08:53:20 UTC 2024: ## Neuralink Receives Approval for First Canadian Brain-Computer Interface Trial
**Toronto, Canada – November 22, 2024** – Elon Musk’s Neuralink has received approval from Health Canada to conduct its first clinical trial in the country. The trial will test the safety and functionality of a brain implant designed to allow individuals with quadriplegia to control digital devices using their thoughts. The University Health Network hospital in Toronto will perform the complex neurosurgical procedures.
This follows Neuralink’s successful implantation of the device in two patients in the United States, where one patient is reportedly using the implant to play video games and create 3D objects. Neuralink aims to eventually use this technology to restore movement, communication, and even vision in disabled patients. The company previously received breakthrough device designation from the U.S. Food and Drug Administration for a similar implant aimed at restoring vision. While Health Canada did not immediately comment on the approval, the news marks a significant step forward for Neuralink’s ambitious brain-computer interface technology.
First Piper 